OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 57.21M
Enterprise Value 33.53M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.66
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.44

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2018
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.69%
Return on Equity (ttm)-78.45%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-13.24M
Diluted EPS (ttm)-0.2350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.75M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)73.22k
Total Debt/Equity (mrq)0.67
Current Ratio (mrq)5.51
Book Value Per Share (mrq)0.19

Cash Flow Statement

Operating Cash Flow (ttm)-9.49M
Levered Free Cash Flow (ttm)-7.73M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.27
52-Week Change 3-68.42%
S&P500 52-Week Change 3-6.95%
52 Week High 30.3900
52 Week Low 30.0800
50-Day Moving Average 30.1259
200-Day Moving Average 30.1799

Share Statistics

Avg Vol (3 month) 31.02M
Avg Vol (10 day) 3618.33k
Shares Outstanding 556.47M
Float 52.17M
% Held by Insiders 18.91%
% Held by Institutions 114.47%
Shares Short (Dec 31, 2018) 41.18M
Short Ratio (Dec 31, 2018) 41.71
Short % of Float (Dec 31, 2018) 42.29%
Short % of Shares Outstanding (Dec 31, 2018) 42.09%
Shares Short (prior month Nov 30, 2018) 41.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/1
Last Split Date 3Jun 3, 2013